Alignment Healthcare, Inc. (ALHC)
| Market Cap | 2.79B -6.3% |
| Revenue (ttm) | 4.58B +37.2% |
| Net Income | 40.70M |
| EPS | 0.20 |
| Shares Out | 207.44M |
| PE Ratio | 68.12 |
| Forward PE | 21.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,645,370 |
| Open | 13.65 |
| Previous Close | 13.96 |
| Day's Range | 13.23 - 13.69 |
| 52-Week Range | 13.05 - 25.12 |
| Beta | 1.13 |
| Analysts | Buy |
| Price Target | 24.08 (+78.9%) |
| Earnings Date | Jul 30, 2026 |
About ALHC
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Financial Performance
In 2025, Alignment Healthcare's revenue was $3.95 billion, an increase of 46.06% compared to the previous year's $2.70 billion. Losses were -$724,000, -99.43% less than in 2024.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for ALHC stock is "Buy." The 12-month stock price target is $24.08, which is an increase of 78.90% from the latest price.
News
Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (ALHC) to Learn More About the Firm's Investigation
New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the ...
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Continues
LOS ANGELES, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP today continues its investigation on behalf of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC)...
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Continues Following Whistleblower Lawsuit Of Financial Manipulation
LOS ANGELES, Aug. 12, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC) on behalf of inv...
Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm About a Potential Securities Claim
NEW YORK, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (N...
Kaplan Fox is Investigating Alignment Healthcare, Inc. (ALHC) for Investors Who Suffered Losses
New York, New York--(Newsfile Corp. - August 12, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the ...
Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (ALHC) of an Ongoing Securities Investigation
New York, New York--(Newsfile Corp. - August 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) ("Alignment Heal...
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities Laws
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) (“...
Kaplan Fox Advises Investors of Alignment Healthcare, Inc. (ALHC) to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "...
Kaplan Fox Notifies Investors of Alignment Healthcare, Inc. (ALHC) of a Securities Law Investigation
New York, New York--(Newsfile Corp. - August 5, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "...
Alignment Healthcare price target lowered to $22 from $26 at JPMorgan
JPMorgan lowered the firm’s price target on Alignment Healthcare (ALHC) to $22 from $26 and keeps an Overweight rating on the shares.
Kaplan Fox Encourages Alignment Healthcare, Inc. (ALHC) Investors to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - August 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "...
Alignment Healthcare price target lowered to $21 from $25 at TD Cowen
TD Cowen analyst Gary Taylor lowered the firm’s price target on Alignment Healthcare (ALHC) to $21 from $25 and keeps a Buy rating on the shares. The firm updated its…
Alignment Healthcare downgraded to Outperform from Strong Buy at Raymond James
Raymond James analyst Parker Snure downgraded Alignment Healthcare (ALHC) to Outperform from Strong Buy with a price target of $19, down from $22. The company’s long-term operating model remains attra...
Alignment Healthcare Earnings Call Transcript: Q2 2026
Q2 2026 saw 31% membership and 32% revenue growth, with Adjusted EBITDA up 48% year-over-year. Guidance for 2026 was raised, reflecting strong first-half results and continued investments in AI, clinical operations, and new market expansion.
Alignment Healthcare Earnings release: Q2 2026
Alignment Healthcare released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Alignment Healthcare Quarterly report: Q2 2026
Alignment Healthcare has published its Q2 2026 quarterly earnings report on July 30, 2026.
Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs
Alignment Healthcare's second quarter net income more than doubled to $36.6 million compared to the year ago period as costs of care for older adults in its Medicare Advantage plans eased.
Alignment Healthcare sees Q3 revenue $1.3B-$1.32B, consensus $1.32B
Sees Q3 adjusted EBITDA $20M-$30M.
Alignment Healthcare sees FY26 revenue $5.2B-$5.23B, consensus $5.19B
Sees FY26 adjusted EBITDA $630M-$650M.
Alignment Healthcare reports Q2 EPS 17c, consensus 20c
Reports Q2 revenue $1.34B, consensus $1.31B. “Our second quarter results underscore the strength of our purpose-built Medicare Advantage platform and place us in a strong position to deliver upon our…
Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics
ORANGE, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its second quarter ended June 30, 2026.
Kaplan Fox Notifies Alignment Healthcare, Inc. (ALHC) Investors of a Securities Investigation into the Company
New York, New York--(Newsfile Corp. - July 29, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "C...
Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation
LOS ANGELES--(BUSINESS WIRE)--Whistleblower suit alleges Alignment misclassified $8-10M as capex to inflate EBITDA. Stock fell 16.7% to $20.03 on 7/8/26 news.
Kaplan Fox Announces a Securities Investigation into Alignment Healthcare, Inc. (ALHC) - Investors Encouraged to Contact the Firm
New York, New York--(Newsfile Corp. - July 17, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "C...
Alignment Healthcare CEO sells $5.92M in common stock
In a regulatory filing, Alignment Healthcare (ALHC) disclosed that its CEO John Kao sold 298K shares of common stock on July 10th in a total transaction size of $5.92M. Published…